Advisory Board

Lord Evans of Weardale KCB

Lord Evans was Director General of MI5 from 2007 to 2013. He spent 33 years with MI5, defending the UK against internal and domestic terrorism and cyber-threats. He was appointed to the Security Service's Management Board as Director of International Counter Terrorism in 2001, ten days before the 9/11 attacks on the World Trade Center. He was appointed to the House of Lords in 2014 at the personal recommendation of the Prime Minister and sits as a cross-bench peer. Lord Evans is also a non-executive Director of HSBC Holdings and of Ark Datacentres Ltd.

Professor Nick Jennings CB FREng

Professor Nick Jennings, CB FREng, is the Vice-Provost for Research and Enterprise at Imperial College London, responsible for promoting, supporting and facilitating their research performance and for leading on the delivery of the Research and Enterprise Strategy. He also holds a chair in Artificial Intelligence in the Departments of Computing and Electrical and Electronic Engineering. Before joining Imperial College London, Professor Jennings was Regius Professor of Computer Science at the University of Southampton and the UK Government’s Chief Scientific Advisor for National Security. Professor Jennings is an internationally-recognized authority in the areas of artificial intelligence, autonomous systems, cybersecurity and agent-based computing. He is a member of the Government’s AI Council.

Alan Wade

Alan Wade had a thirty-five-year career in the Central Intelligence Agency, where he latterly served as the Chief Information Officer, before his retirement in 2005. Prior to this role, Alan held a series of senior positions at the CIA, including the Director of Communications and Director of Security. Alan is a recipient of the National Intelligence Distinguished Service Medal, the Director’s Medal, and the Distinguished Intelligence Medal. He also serves on the boards of the Aerospace Corporation in El Segundo, CA, Professional Project Services in Oak Ridge, TN and Assyst Inc in Herndon, VA.

Dr Mike Lynch OBE

Having pioneered three of the biggest success stories in UK tech, Autonomy, Blinkx and Darktrace, Mike is regarded as Britain's most established technology entrepreneur. Spun out from his previous company, Neurodynamics, which he sold in 2005, Mike founded Autonomy in 1996 based on technology invented at Cambridge University, where Dr Lynch studied Information Sciences, received a Ph.D. and held a research fellowship in adaptive pattern recognition. He served as CEO of Autonomy for over fifteen years, during which time it became one of the UK's most successful technology companies on the FTSE 100. Autonomy was acquired by HP for $11 billion in 2011.

Mike founded Invoke Capital in 2012 to support world-leading fundamental technology businesses emerging across Europe. Since then, Invoke has been instrumental in developing and scaling prominent UK tech companies from innovative start-ups out of Cambridge University into global businesses. Portfolio companies include Luminance, an award-winning machine learning platform for the legal industry, and Darktrace, a world-leading cyber AI company that employs more than 1,000 people globally.

Referred to as the UK’s answer to Bill Gates, Mike has won numerous awards, including Computer Weekly's 'Most Influential Person of the Year' and the Chartered Institute for IT's award for Outstanding Contribution to IT in 2011. He was awarded an OBE for Services to Enterprise in 2006 and was elected to the Prime Minister’s Council for Science and Technology in 2011. Mike is a fellow of the Royal Academy of Engineering and an honorary fellow of Christ's College Cambridge. He was also elected a Fellow of the Royal Society in April 2014 and a trustee of the National Endowment for Science Technology and the Arts (NESTA) in 2010.

Mike is a generous supporter of many causes, including the Royal Botanic Gardens Kew, Cancer Research UK, Cambridge University, The Prince’s Trust’s technology group and a number of educational charities. He also contributes to conservation charities and preserves rare breeds.

Next: Investors